Actively Recruiting
Impact of Combined Oral Contraceptive Pills on Migraine
Led by Kafrelsheikh University · Updated on 2024-10-09
400
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs.
CONDITIONS
Official Title
Impact of Combined Oral Contraceptive Pills on Migraine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female migraine patients aged 18 to 55 years
- Diagnosed according to the International Classification of Headache Disorders 3rd edition
- Currently using combined oral contraceptive pills or mechanical contraceptive methods
You will not qualify if you...
- Patients with major neurological conditions such as epilepsy, ischemic or hemorrhagic stroke, multiple sclerosis, mitochondrial diseases, or brain tumors
- Pregnant, breastfeeding, or menopausal patients
- Patients with contraindications to ibuprofen or propranolol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt, 33511
Actively Recruiting
Research Team
M
mohamed G. Zeinhom, MD
CONTACT
S
sherihan R. ahmed, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here